Bo Ding
- Cancer Research top 5%
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 5%
- Signaling Pathways in Disease 8
-
- Diabetes Treatment and Management 14
- Diabetes Management and Research 12
- Hormonal and reproductive studies 7
- Neurology top 10%
-
- Diabetes and associated disorders 7
-
- Pharmacology and Obesity Treatment 7
- Co-authors
- Jun‐ichi AbeYan ChenChang‐seng LiangWeike MaoJiahao LiuBradford C. BerkJianhua MaBeverly H. Lorell
- Journals
- Diabetes Therapy (7 papers)Circulation Research (5 papers)Frontiers in Endocrinology (5 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Bo Ding
103 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 112
- Cardiology and Cardiovascular Medicine 618
- Cancer Research 372
- Molecular Biology 1.5k
- Endocrinology, Diabetes and Metabolism 278
- Neurology 86
Countries citing papers authored by Bo Ding
This map shows the geographic impact of Bo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ding more than expected).
Fields of papers citing papers by Bo Ding
This network shows the impact of papers produced by Bo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ding. The network helps show where Bo Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 37 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 36 | |
| 16 | 2019 | 10 | |
| 17 | 2015 | 1 | |
| 18 | Application of continuous glucose monitoring system to explore the blood glucose fluctuation model of insulinoma | 2013 | 1 |
| 19 | 2010 | 0 | |
| 20 | Effect of PKC-zeta mediating Ang II-stimulated activation of CCDPK on rat cardiac fibroblast proliferation. | 2000 | 3 |
About Bo Ding
Bo Ding is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology, having authored 110 papers that have together received 2.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (12 papers), MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers), Signaling Pathways in Disease (8 papers), Diabetes and associated disorders (7 papers), Pharmacology and Obesity Treatment (7 papers) and Hormonal and reproductive studies (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (618 citations), Cancer Research (372 citations) and Molecular Biology (1.5k citations). Bo Ding has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jun‐ichi Abe, Yan Chen, Chang‐seng Liang, Weike Mao, Jiahao Liu, Bradford C. Berk, Jianhua Ma, Beverly H. Lorell, Wenyi Che and Burns C. Blaxall. Their work appears in journals such as Diabetes Therapy, Circulation Research, Frontiers in Endocrinology, Circulation and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.